The biological significance of vitamin D receptors expressed by gliobl
astoma and other glial tumours is still unclear. In an effort to clari
fy this issue we studied the effects of increasing concentrations of 2
5-dihydroxyvitamin D-3 and its metabolite 1 alpha,25-dihydroxyvitamin
D-3 on two human glioblastoma cell lines. Both substances were capable
of inducing a significant(> 50%) reduction in growth of the two gliob
lastoma cell lines at dosages over 5 mu M. When the HU 70 cell line wa
s treated by increasing dilutions of 25-dihydroxyvitamin D-3 combined
with 1 mu M all trans-retinoic acid, significant inhibition was appare
nt even after addition of 25-dihydroxyvitamin D-3 in the nanomolar ran
ge. Reduction of growth index was mainly due to induced cell death. Ou
r results provide in vitro evidence that vitamin D metabolites alone o
r in combination with retinoids may be potentially useful agents in th
e differentiation therapy of human malignant gliomas.